268 related articles for article (PubMed ID: 16540656)
1. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer.
Wang B; Hendricks DT; Wamunyokoli F; Parker MI
Cancer Res; 2006 Mar; 66(6):3071-7. PubMed ID: 16540656
[TBL] [Abstract][Full Text] [Related]
2. A key role for early growth response-1 and nuclear factor-kappaB in mediating and maintaining GRO/CXCR2 proliferative signaling in esophageal cancer.
Wang B; Khachigian LM; Esau L; Birrer MJ; Zhao X; Parker MI; Hendricks DT
Mol Cancer Res; 2009 May; 7(5):755-64. PubMed ID: 19435811
[TBL] [Abstract][Full Text] [Related]
3. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism.
Loukinova E; Dong G; Enamorado-Ayalya I; Thomas GR; Chen Z; Schreiber H; Van Waes C
Oncogene; 2000 Jul; 19(31):3477-86. PubMed ID: 10918606
[TBL] [Abstract][Full Text] [Related]
4. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
[TBL] [Abstract][Full Text] [Related]
5. GROβ and its downstream effector EGR1 regulate cisplatin-induced apoptosis in WHCO1 cells.
Dong Q; Zhang J; Hendricks DT; Zhao X
Oncol Rep; 2011 Apr; 25(4):1031-7. PubMed ID: 21271225
[TBL] [Abstract][Full Text] [Related]
6. Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8.
Qian YQ; Johanson KO; McDevitt P
J Mol Biol; 1999 Dec; 294(5):1065-72. PubMed ID: 10600366
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
Katancik JA; Sharma A; de Nardin E
Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
[TBL] [Abstract][Full Text] [Related]
8. Impaired interleukin-8- and GROalpha-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia.
Fuhler GM; Knol GJ; Drayer AL; Vellenga E
J Leukoc Biol; 2005 Feb; 77(2):257-66. PubMed ID: 15561756
[TBL] [Abstract][Full Text] [Related]
9. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
[TBL] [Abstract][Full Text] [Related]
10. Induction of C-X-C chemokines, growth-related oncogene alpha expression, and epithelial cell-derived neutrophil-activating protein-78 by ML-1 (interleukin-17F) involves activation of Raf1-mitogen-activated protein kinase kinase-extracellular signal-regulated kinase 1/2 pathway.
Kawaguchi M; Kokubu F; Matsukura S; Ieki K; Odaka M; Watanabe S; Suzuki S; Adachi M; Huang SK
J Pharmacol Exp Ther; 2003 Dec; 307(3):1213-20. PubMed ID: 14557379
[TBL] [Abstract][Full Text] [Related]
11. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
Ahuja SK; Murphy PM
J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
[TBL] [Abstract][Full Text] [Related]
12. Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines.
Moscova M; Marsh DJ; Baxter RC
Cancer Res; 2006 Feb; 66(3):1376-83. PubMed ID: 16452192
[TBL] [Abstract][Full Text] [Related]
13. CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation.
Barbieri F; Bajetto A; Porcile C; Pattarozzi A; Massa A; Lunardi G; Zona G; Dorcaratto A; Ravetti JL; Spaziante R; Schettini G; Florio T
Ann N Y Acad Sci; 2006 Dec; 1090():332-43. PubMed ID: 17384278
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of GROalpha-induced human endothelial cell proliferation by the alpha-chemokine inhibitor antileukinate.
Fujisawa N; Hayashi S; Kurdowska A; Carr FK; Miller EJ
Cytokine; 1999 Mar; 11(3):231-8. PubMed ID: 10209071
[TBL] [Abstract][Full Text] [Related]
15. CXC chemokines and their receptors are expressed in type II cells and upregulated following lung injury.
Vanderbilt JN; Mager EM; Allen L; Sawa T; Wiener-Kronish J; Gonzalez R; Dobbs LG
Am J Respir Cell Mol Biol; 2003 Dec; 29(6):661-8. PubMed ID: 12829448
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431.
Metzner B; Hofmann C; Heinemann C; Zimpfer U; Schraufstätter I; Schöpf E; Norgauer J
Oncol Rep; 1999; 6(6):1405-10. PubMed ID: 10523720
[TBL] [Abstract][Full Text] [Related]
17. Regulation of growth-regulated oncogene alpha expression by estrogen in human endothelial cells.
Lei ZB; Li XY; Wang BC; Yang YF; You NZ; Sun J
Acta Pharmacol Sin; 2001 Nov; 22(11):1003-6. PubMed ID: 11749791
[TBL] [Abstract][Full Text] [Related]
18. An activated Notch1 signaling pathway inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cell line EC9706.
Lu Z; Liu H; Xue L; Xu P; Gong T; Hou G
Int J Oncol; 2008 Mar; 32(3):643-51. PubMed ID: 18292942
[TBL] [Abstract][Full Text] [Related]
19. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.
Wente MN; Keane MP; Burdick MD; Friess H; Büchler MW; Ceyhan GO; Reber HA; Strieter RM; Hines OJ
Cancer Lett; 2006 Sep; 241(2):221-7. PubMed ID: 16458421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
